Literature DB >> 18184149

Risk of recurrence after a first unprovoked seizure.

Anne T Berg1.   

Abstract

The risk of recurrence after a first unprovoked seizure has been examined in numerous observational studies and two large, high-quality randomized trials. Overall, in untreated individuals, 40-50% can expect a recurrence within 2 years of the initial seizure. Treatment may reduce this risk by as much as half. Those at the greatest risk of recurrence have either an abnormal EEG or an identifiable neurological condition or symptoms consistent with one ("symptomatic"). Status epilepticus and a history of febrile seizures may be associated with an increased risk of recurrence in individuals with symptomatic seizures. The great majority of people (approximately 90%) who are seen for a first unprovoked seizure attain a one to two year remission within 4 or 5 years of the initial event.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184149     DOI: 10.1111/j.1528-1167.2008.01444.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  27 in total

1.  Evidence-Based Guideline: Management of an Unprovoked First Seizure in Adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  A Krumholz; S Wiebe; G S Gronseth; D S Gloss; A M Sanchez; A A Kabir; A T Liferidge; J P Martello; A M Kanner; S Shinnar; J L Hopp; J A French
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

2.  Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  Allan Krumholz; Samuel Wiebe; Gary S Gronseth; David S Gloss; Ana M Sanchez; Arif A Kabir; Aisha T Liferidge; Justin P Martello; Andres M Kanner; Shlomo Shinnar; Jennifer L Hopp; Jacqueline A French
Journal:  Neurology       Date:  2015-04-21       Impact factor: 9.910

3.  Safe Treatment of Seizures in the Setting of HIV/AIDS.

Authors:  Omar Siddiqi; Gretchen L Birbeck
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

4.  Epilepsy Among Elderly Medicare Beneficiaries: A Validated Approach to Identify Prevalent and Incident Epilepsy.

Authors:  Lidia M V R Moura; Jason R Smith; Deborah Blacker; Christine Vogeli; Lee H Schwamm; Andrew J Cole; Sonia Hernandez-Diaz; John Hsu
Journal:  Med Care       Date:  2019-04       Impact factor: 2.983

Review 5.  Acute Symptomatic Seizures and Provoked Seizures: to Treat or Not to Treat?

Authors:  Nisali Gunawardane; Madeline Fields
Journal:  Curr Treat Options Neurol       Date:  2018-08-23       Impact factor: 3.598

6.  EEG for children with complex febrile seizures.

Authors:  Pankaj B Shah; Saji James; Sivaprakasam Elayaraja
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

7.  Treating epilepsy across its different stages.

Authors:  Ettore Beghi
Journal:  Ther Adv Neurol Disord       Date:  2010-03       Impact factor: 6.570

8.  Management of epilepsy in brain tumors.

Authors:  Marta Maschio; Umberto Aguglia; Giuliano Avanzini; Paola Banfi; Carla Buttinelli; Giuseppe Capovilla; Marina Maria Luisa Casazza; Gabriella Colicchio; Antonietta Coppola; Cinzia Costa; Filippo Dainese; Ornella Daniele; Roberto De Simone; Marica Eoli; Sara Gasparini; Anna Teresa Giallonardo; Angela La Neve; Andrea Maialetti; Oriano Mecarelli; Marta Melis; Roberto Michelucci; Francesco Paladin; Giada Pauletto; Marta Piccioli; Stefano Quadri; Federica Ranzato; Rosario Rossi; Andrea Salmaggi; Riccardo Terenzi; Paolo Tisei; Flavio Villani; Paolo Vitali; Lucina Carla Vivalda; Gaetano Zaccara; Alessia Zarabla; Ettore Beghi
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

9.  A seizure attributed to ofloxacine in a woman undergoing detoxification for alcohol dependence.

Authors:  Pierre Lahmek; Laurent Michel; Nadine Meunier; Henri-Jean Aubin
Journal:  Case Rep Med       Date:  2010-01-24

10.  Stopping antiepileptic drugs: when and why?

Authors:  John D Hixson
Journal:  Curr Treat Options Neurol       Date:  2010-06-26       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.